ZLZydus Lifesciences532321Compliance inspection

USFDA inspection at Moraiya plant concludes with 5 observations

The USFDA inspected Zydus' manufacturing plant at Moraiya, Ahmedabad.

By ScoutQuest · Tue 13 Oct 2026, 8:29 PM IST · 1 min read

Number of USFDA observations

5

Inspection period

5th to 13th October 2026

Plant location

Moraiya, Ahmedabad

What was announced

Zydus Lifesciences informed the stock exchanges about the conclusion of a USFDA inspection at its manufacturing plant located at Moraiya, Ahmedabad.

• The inspection was conducted from 5th to 13th October 2026.
• The inspection closed with 5 observations.
• The company stated that it will closely work with the USFDA to address the observations expeditiously.

Reading the key words

• An inspection is a regulatory check carried out by the USFDA at the plant.
• "Observations" are the points recorded by the inspecting team when the inspection closes. Here the count is 5.
• The company has set out its intention to work with the USFDA to address them.

Numbers to note

• Number of observations: 5
• Inspection period: 5th to 13th October 2026

What investors may track

• The inspection has concluded with observations, and the company has said it will work with the USFDA to address them.
• Follow-up disclosures on how these observations are resolved are what investors typically keep an eye on.

In short: the plant's USFDA inspection is over, closing with 5 observations, and the company has said it will address them with the regulator.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev